[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"covid-long-haul\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:covid-long-haul":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,42,66,90],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100556674","covid-19-long-immunit-imagerie-cliim-100556674",false,"NCT06528171","Covid-19 Long Immunité IMagerie (CLIIM)","Specific Markers of Covid-long Syndrome: Identifying the Mechanisms Involved With a View to Defining Diagnostic Criteria","CLIIM","FOR CL+ PATIENTS\n\nInclusion Criteria:\n\n* Case definition in line with WHO Delphi process\n\nExclusion Criteria:\n\n* History of chronic fatigue syndrome diagnosed before or after Covid.\n* History of progressive psychiatric pathology.\n* History of acute Covid requiring admission to intensive care and mechanical ventilation.\n* No social security affiliation.\n\nFOR CONTROL (CL-)\n\nInclusion Criteria:\n\n* History of acute COVID-19, mild, moderate or severe (episode at least 3 months at the time of inclusion).\n* Absence of persistent symptoms more than 3 months after first Covid symptoms (or mild not affecting daily activities).\n\nExclusion Criteria:\n\n* History of progressive psychiatric pathology.\n* History of acute Covid requiring admission to intensive care and mechanical ventilation.\n* No social security affiliation.\n* Pregnant or breast-feeding.",true,"ALL","18 Years",{"count":21,"type":22},200,"ESTIMATED","INTERVENTIONAL",[25],"NA","Covid-long pathology affects a large number of patients, and represents a major medical, economic and societal challenge. To date, we have no objective criterion for a definitive diagnosis, nor any predictive tool for monitoring the evolution of Covid-long. Based on recruitment from the infectious diseases department of Nice University Hospital, the investigator's team wants to conduct an innovative pathophysiological study to better define the disease and identify specific biomarkers that could subsequently be used as a diagnostic tool for Covid-long. 120 participants will be initially included for the model learning phase: 60 controls in the CL- cohort and 60 patients in the CL+ cohort. Then 80 patients (40 CL+ and 40 Cl-) will be enrolled for the model validation phase.",[28],"COVID Long-Haul","RECRUITING","2026-06-18",{"date":32,"type":33},"2026-06-22","ACTUAL",{"date":35,"type":33},"2024-12-06",{"date":37,"type":22},"2028-06",{"name":39,"class":40},"Centre Hospitalier Universitaire de Nice","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":18,"minAge":49,"maxAge":19,"enrollmentInfo":50,"targetDuration":4,"studyType":23,"phases":52,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":41},"100437614","percutaneous-electrical-nerve-field-stimulation-penfs-in-patients-with-post-concussion-syndrome-pcs-100437614","NCT04978571","Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)","A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)","Concussion:\n\nInclusion Criteria:\n\n* Clinical diagnosis of Post-Concussion Syndrome\n* Post-Concussion Symptoms for at least 3 months along with lack of other explanation for their symptoms\n* English and Spanish-speaking families\n\nExclusion Criteria:\n\n* Seizure disorders\n* Significant developmental delay\n* Infection or severe dermatological condition of ear\n* Bleeding disorders\n* Implanted electrical device\n\nCOVID:\n\nInclusion Criteria\n\n* Child is in between the ages 11-18\n* Child is present at CHOC Neurology clinic post covid-19 symptoms of more than 3 months duration along with lack of other explanation for their symptoms\n* English-speaking and Spanish-speaking families\n\nYou cannot participate in this study if you meet the following exclusion criteria:\n\n* Children with significant developmental delay, infection or severe dermatological condition of ear, bleeding disorders, or having any implanted electrical device will be excluded.\n* Are not able to attend Friday appointments for the Neurostim placements.","11 Years",{"count":51,"type":22},125,[25],"The purpose of this study is to test the effect of Auricular Percutaneous Electrical Nerve Field Stimulation (a Neurostim device) on children with pain and Post Concussion symptoms.\n\nAn additional purpose of this study is to demonstrate that PENFS improves functioning in children with post Covid-19 symptoms.",[55,28,56],"Post-Concussion Syndrome","COVID-19","2026-03-16",{"date":59,"type":33},"2026-03-18",{"date":61,"type":33},"2021-02-01",{"date":63,"type":22},"2027-01",{"name":65,"class":40},"Children's Hospital of Orange County",{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":4,"eligibilityCriteria":72,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":73,"enrollmentInfo":74,"targetDuration":4,"studyType":23,"phases":76,"briefSummary":77,"conditions":78,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":41},"100519575","mind-body-intervention-for-long-covid-19-100519575","NCT06045338","Mind Body Intervention for Long COVID-19","Mind Body Intervention for Long COVID","Inclusion Criteria:\n\n1. Adult (≥ 18 years of age)\n2. Infection with Sars-COV2 (i. e., positive antibody, antigen, or PCR testing)\n3. Symptoms attributed only to COVID-19 and not to known comorbid disease (e.g., other infections, cancer, etc)\n4. A somatic symptom score ≥ 10 on the SSS-8 questionnaire with involvement of at least 3 domains\n5. Symptoms present at least 3 day a week for a minimum of 3 months\n6. Willingness to engage in a Mind-Body intervention\n\nExclusion Criteria:\n\n1. Clear diagnosis of physical disease (e.g. lung fibrosis, myocarditis) not inclusive of non-specific findings such as mild arthritis\n2. Hospitalization in an intensive care unit for acute COVID-19 infections\n3. Age greater than 65 years\n4. Diagnosis of dementia or similar cognitive impairment\n5. Active addiction disorder (e.g. cocaine) that would interfere with study participation\n6. Major psychiatric comorbidity (e.g., schizophrenia). Mild to moderate anxiety and depression are not considered in this category","65 Years",{"count":75,"type":22},180,[25],"The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates individual somatic complaints and improves daily functioning, relative to usual care and the active control",[79,80,28],"Long COVID","Post-Acute Sequelae of COVID-19","2026-02-16",{"date":83,"type":33},"2026-02-18",{"date":85,"type":33},"2023-11-09",{"date":87,"type":22},"2026-12",{"name":89,"class":40},"Beth Israel Deaconess Medical Center",{"id":91,"slug":92,"hasResults":11,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":96,"eligibilityCriteria":97,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":98,"targetDuration":4,"studyType":23,"phases":100,"briefSummary":101,"conditions":102,"keywords":107,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":41},"100603713","long-covid-19-alleviation-through-learning-mindfulness-study-100603713","NCT07140094","Long-Covid-19 Alleviation Through Learning Mindfulness Study","Long-Covid-19 Alleviation Through Learning Mindfulness Study (LONG-CALM)","LONG-CALM","Inclusion Criteria:\n\n* Age \\> or = 18\n* Willing and able to provide informed consent\n* Access to the internet\n* Self-reported history of SARS-CoV-2 infection\n* Current symptoms attributed to PASC by participant or by participant's medical provider; ongoing symptoms that persisted \\>= 12 weeks after Covid-19 illness\n\nExclusion Criteria:\n\n* Participating in another clinical trial of an intervention for PASC symptoms\n* Engaged in a structured MBI",{"count":99,"type":22},400,[25],"This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined as paying attention to the present moment with non-judgment and acceptance. Here the investigators are studying whether a mindfulness intervention can help reduce stress, reduce Long COVID symptoms, and improve quality of life among people living with Long COVID. The mindfulness intervention is a series of recorded mindfulness sessions, which were created by the study team. People who decide to take part will be randomly assigned to receive the study mindfulness intervention immediately after joining the study or to receive the study mindfulness intervention 8 weeks after joining the study. All participants will continue their usual medical care. Participants will complete online surveys to measure symptoms over time. The study will last 6 months.",[79,103,104,105,106,28],"Long Covid19","Post-Acute COVID-19","Post-Acute COVID-19 Syndrome","Post-Acute COVID-19 Infection",[108],"Covid","2025-08-21",{"date":111,"type":33},"2025-08-24",{"date":113,"type":33},"2024-05-21",{"date":115,"type":22},"2027-11-21",{"name":117,"class":40},"Columbia University"]